Evaluation of Patient Stress Level Caused by Radiological Investigations in Early Postoperative Phase After Craniotomy
NCT05112575 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 152
Last updated 2023-12-07
Summary
Postoperative imaging after neurosurgical intervention is usually performed in the first 72 hours after surgery. Postoperative radiological examinations in the first 72 hours provide accurate assessment of postoperative resection status. On the other side is frequently reported by patients that the earlier postoperative examinations after craniotomy for tumor and vascular procedures are associated with distress, exertion, nausea, and pain. Therefore, psychological and physical stress on the patient could be a potential disadvantage of earlier (up to 36 hours postoperatively) follow-up. The goal of this study is to evaluate and determine the optimal time frame for postoperative imaging with MRI and CT in terms of medical and neuroradiological implications and patient's subjective stress.
The primary endpoint of the study is the extent of subjective distress due to postoperative MRI and CT monitoring in relation to the time interval after surgery Data will be prospectively collected from all patients aged 18 to 80 years who receive postoperative MRI or CT follow-up after craniotomy for resection of a cerebral tumor (benign and malignant) or vascular surgery.
This study determines, whether a timing of postoperative imaging can improve patient satisfaction and reduce pain, stress and discomfort caused by postoperative imaging. The outcome corresponds to the value-based medicine approach of modern patient-centred medicine. Results will be published in peer-reviewed journals and electronic patient data will be safely stored for 15 years.
Conditions
- Postoperative Pain
- Postoperative Nausea
Interventions
- RADIATION
-
Postoperative imaging with magnetic resonance imaging or computed tomography
Postoperative imaging control with magnetic resonance or computed tomography after craniotomy for vascular or neurooncological operations.
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-20
- Primary Completion
- 2023-01-31
- Completion
- 2023-02-01
Countries
- Switzerland
Study Locations
More Related Trials
-
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor
NCT02791360 ·Status: COMPLETED ·Phase: NA
-
Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery
NCT03624114 ·Status: COMPLETED
-
Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors
NCT00075166 ·Status: COMPLETED ·Phase: PHASE4
-
Neurococognitive and Functioal Assessment of Patients With Brain Metastases
NCT01861405 ·Status: UNKNOWN
-
Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
NCT02540135 ·Status: WITHDRAWN ·Phase: NA
-
Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas
NCT04766632 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
NCT03903419 ·Status: UNKNOWN ·Phase: NA
-
MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning
NCT01534104 ·Status: COMPLETED ·Phase: NA
-
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
NCT01417507 ·Status: COMPLETED
-
Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children
NCT06226519 ·Status: RECRUITING
-
Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
NCT00904553 ·Status: COMPLETED
-
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
NCT02371031 ·Status: TERMINATED ·Phase: PHASE1
-
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
NCT03534050 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies
NCT06199479 ·Status: RECRUITING ·Phase: PHASE1
-
Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
NCT07119294 ·Status: RECRUITING ·Phase: NA
-
Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
NCT01798771 ·Status: UNKNOWN ·Phase: NA
-
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
NCT05212272 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Use of Radiomics in 18F-FDOPA PET Examinations for the Characterization of Gliomas
NCT04469244 ·Status: COMPLETED
-
Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors
NCT03394716 ·Status: TERMINATED
-
Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
NCT05896449 ·Status: COMPLETED ·Phase: NA
-
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NCT04033497 ·Status: RECRUITING ·Phase: NA
-
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
NCT01579253 ·Status: UNKNOWN
-
Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
NCT01212731 ·Status: COMPLETED
-
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
NCT05970757 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA